Corcept Therapeutics (CORT)
NASDAQ: CORT
· Real-Time Price · USD
77.54
-0.10 (-0.13%)
At close: May 30, 2025, 3:59 PM
77.75
0.27%
After-hours: May 30, 2025, 05:13 PM EDT
Corcept Therapeutics Revenue
Corcept Therapeutics reported an annual revenue of $675.04M, reflecting a 39.94% growth. For the quarter ending March 31, 2025, Corcept Therapeutics generated $157.21M in revenue.
Revenue (ttm)
$675.04M
Revenue Growth
39.94%
Price / Sales Ratio
7.71
Revenue / Employee
$1.35M
Employees
500
Market Cap
8.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|